MLAB provides press release with results for period ended Sept 30, 2025

Rhea-AI Filing Summary

Mesa Laboratories (MLAB) announced it issued a press release covering results for the three and six months ended September 30, 2025. The company furnished the press release as Exhibit 99.1 to this Form 8‑K.

The information provided with the press release is being furnished, not filed, which means it is not subject to Section 18 liabilities and is not incorporated by reference into Securities Act filings. The filing lists MLAB common stock on The Nasdaq Stock Market LLC.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0000724004 0000724004 2025-11-06 2025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549   

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): NOVEMBER 6, 2025

MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

colorado
(State or other jurisdiction of
incorporation) 0-11740 (Commission File Number) 84-0872291
(I.R.S. Employer
Identification No.)

12100 west sixth avenue, lakewood, colorado
(Address of principal executive offices) 80228
(Zip Code)

Registrant’s telephone number, including area code: 303-987-8000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, no par value		MLAB		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On November 6, 2025, Mesa Laboratories, Inc. issued a press release relating to its results for the three and six months ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits:

99.1 Press release dated November 6, 2025.

104 Cover Page Interactive Data File (embedded withing the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATE: November 6, 2025		Mesa Laboratories, Inc.
		(Registrant)
	BY:	/s/ Gary M. Owens
		Gary M. Owens
		President and Chief Executive Officer

FAQ

What did Mesa Laboratories (MLAB) announce in this 8-K?

The company furnished a press release with results for the three and six months ended September 30, 2025, as Exhibit 99.1.

Which period does the MLAB press release cover?

It covers the three and six months ended September 30, 2025.

How is the press release treated legally in this filing?

It is furnished, not filed, and is not subject to Section 18 liabilities or incorporated by reference under the Securities Act.

Where can I find the detailed results for MLAB?

See Exhibit 99.1 to this Form 8-K, which contains the full press release.

What is Mesa Laboratories’ trading symbol and exchange?

The company’s common stock trades under the symbol MLAB on The Nasdaq Stock Market LLC.

Who signed the MLAB 8-K?

It was signed by Gary M. Owens, President and Chief Executive Officer.